Smartleaf Asset Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Smartleaf Asset Management's MXCT Position: Q1 2026 in Review
Smartleaf Asset Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 1,881 shares — an estimated $2.93K sold.
Smartleaf Asset Management first reported a position in MXCT in Q3 2024 and held it in 5 quarters. The position peaked at $2.93K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Smartleaf Asset Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
- Smartleaf Asset Management sold 1,881 MaxCyte shares in Q1 2026, an estimated $2.93K.
- Smartleaf Asset Management first reported a position in MaxCyte in Q3 2024 and held it in 5 quarters.
- Smartleaf Asset Management's MaxCyte position peaked at $2.93K in Q4 2025.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.